Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation

[1]  N. Hill,et al.  CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension , 2021, International journal of molecular sciences.

[2]  Yan-ting Zhu,et al.  Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP , 2021, Molecular and Cellular Biochemistry.

[3]  A. Mashaghi,et al.  Reciprocal regulation of cellular mechanics and metabolism , 2021, Nature Metabolism.

[4]  anna shen,et al.  Osteoprotegerin prompts cardiomyocyte hypertrophy via autophagy inhibition mediated by FAK/BECLIN1 pathway. , 2020, Life sciences.

[5]  Yan-ting Zhu,et al.  Sphingosine-1-phosphate promotes pulmonary artery smooth muscle cells proliferation by stimulating autophagy-mediated E-cadherin/CDH1 down-regulation. , 2020, European journal of pharmacology.

[6]  Ling-Yun Wu,et al.  Osteopontin-Enhanced Autophagy Attenuates Early Brain Injury via FAK–ERK Pathway and Improves Long-Term Outcome after Subarachnoid Hemorrhage in Rats , 2019, Cells.

[7]  Yun Liu,et al.  Metformin Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Activation of Adenosine Monophosphate-Activated Protein Kinase , 2019, Journal of Vascular Research.

[8]  Huang Huang,et al.  NSD2 silencing alleviates pulmonary arterial hypertension by inhibiting trehalose metabolism and autophagy. , 2019, Clinical science.

[9]  S. Taheri,et al.  FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells , 2019, Journal of Molecular Medicine.

[10]  Qingting Wang,et al.  Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy , 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  Jing Li,et al.  Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension. , 2018, Cellular signalling.

[12]  You-yang Zhao,et al.  Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension , 2018, American journal of respiratory and critical care medicine.

[13]  Yan-ting Zhu,et al.  Activation of AMPK prevents monocrotaline‐induced pulmonary arterial hypertension by suppression of NF‐&kgr;B‐mediated autophagy activation , 2018, Life sciences.

[14]  R. Chen,et al.  The role of autophagy in pulmonary hypertension: a double-edge sword , 2018, Apoptosis.

[15]  Ai-Qin Jiang,et al.  FAK inhibitors in Cancer, a patent review , 2018, Expert opinion on therapeutic patents.

[16]  S. Breuils-bonnet,et al.  FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension , 2018, Journal of Molecular Medicine.

[17]  J. Melo,et al.  Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition , 2017, Journal of the National Cancer Institute.

[18]  Deeptashree Nandi,et al.  FoxM1: Repurposing an oncogene as a biomarker. , 2017, Seminars in cancer biology.

[19]  B. Ozpolat,et al.  FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer , 2017, Breast Cancer Research and Treatment.

[20]  Guilin Chen,et al.  Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin &agr;v&bgr;3/FAK/AKT Pathway Suppression , 2017, Circulation. Cardiovascular genetics.

[21]  A. Leite-Moreira,et al.  Pulmonary arterial hypertension: Basic knowledge for clinicians. , 2016, Archives of cardiovascular diseases.

[22]  M. Narasimhan,et al.  A review of therapeutic agents for the management of pulmonary arterial hypertension , 2016, Therapeutic advances in respiratory disease.

[23]  P. Zhou,et al.  Autophagy as the effector and player in DNA damage response of cells to genotoxicants , 2015 .

[24]  E. Lam,et al.  FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance , 2014, Biochimica et biophysica acta.

[25]  S. Provencher,et al.  Targeting cell motility in pulmonary arterial hypertension , 2013, European Respiratory Journal.

[26]  N. Morrell,et al.  Chloroquine Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Lysosomal Bone Morphogenetic Protein Type II Receptor Degradation , 2013, Circulation research.

[27]  A. Gartel,et al.  FOX(M1) News—It Is Cancer , 2013, Molecular Cancer Therapeutics.

[28]  A. Simon,et al.  Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging , 2012, Cellular and Molecular Life Sciences.

[29]  B. Dahal,et al.  Integrative Physiology/experimental Medicine Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension Materials and Methods Mct Treatment, Inhibitor Treatment, and Hemodynamic Measurements Assessment of Vascular Remodeling and Proliferation in Situ Cell Culture Proliferation Assays Chemot , 2022 .

[30]  J. Guan,et al.  Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. , 2011, Advanced drug delivery reviews.

[31]  N. Morrell,et al.  Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. , 2010, Comprehensive Physiology.

[32]  M. Eck,et al.  The FERM domain: organizing the structure and function of FAK , 2010, Nature Reviews Molecular Cell Biology.

[33]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[34]  H. Shimokawa,et al.  Identification of new prognostic factors of pulmonary hypertension. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[35]  Sandra Barth,et al.  Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.

[36]  Daniel A. Fletcher,et al.  Cell mechanics and the cytoskeleton , 2010, Nature.

[37]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[38]  I. Wierstra,et al.  The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. , 2013, Advances in cancer research.